#Key Graphs
Graphs:
* Help you to convey knowledge and understanding efficiently in the written
* Are often a feature of the viva as they allow examiners to assess depth of understanding
	* You will be asked to demonstrate how they change under different physiological states

It is easy to get distracted by the curve, and forget the basics (especially in the written). To avoid this, approach them in the same way each time:
* **Axis**  
First draw the axis.
	* If the axis is continuous (e.g. PaO<sub>2</sub>), ensure you place an arrow at the far end
	* If the axis ends at a fixed point (e.g. SpO<sub>2</sub>), ensure you place a bar at the end to signify it does not continue indefinitely
* **Labels**  
Label each axis with what it is representing.
* **Units**  
Give each label **appropriate units**.
	* In the viva, you can just say this out loud as you're drawing the axes
* **Curve**  
Draw the curve.
* **Special Points**  
Identify the key points of the curve and label these points. These include:
	* Intercepts
	* Inflection points 
	* Important values  
	e.g. The mixed venous point.

##Pharmacology
**Dose-Response:**  
<object data="resources\dose-response.svg" type="image/svg+xml"></object>

* Dose response curve is a wash-in exponential
* Difficult to compare different drugs using this curve

**Log<sub>Dose</sub>-Response:**  
<object data="resources\fatex.svg" type="image/svg+xml"></object>

* Log-transform of dose allows different drugs to be compared
* Both red and blue drugs are full agonists (as they both reach 100% response), however the blue drug is more potent as it has a lower E<sub>D</sub>50

**Agonists:**  
<object data="resources\agonists-FA-IA-PA.svg" type="image/svg+xml"></object>

* Partial agonists do not reach 100% response
* Inverse agonists have a negative response

**Antagonists:**  
<object data="resources\FA-with-nca-and-ca.svg" type="image/svg+xml"></object>

* Non-competitive antagonists prevent maximal response being reached
* Competitive agonists right shift the curve, as they can be overcome with increasing dose of agonist

**Therapeutic Index:**  
<object data="resources\therapeutic-index.svg" type="image/svg+xml"></object>

* Can be calculated from the ratio of the LD<sub>50</sub> and ED<sub>50</sub>


###Models
**The One-Compartment Model:**  
<object data="resources\1compartment.svg" type="image/svg+xml"></object>

* Drug is added to and removed from the single central compartment  
There is no distribution possible.
* V<sub>1</sub> is equal to the volume of distribution
* k<sub>10<sub> is the rate constant for elimination

**Three-Compartment Model:**  
<object data="resources\3compartment.svg" type="image/svg+xml"></object>

* Drug is added to and removed from the central compartment
* Drug will also distribute to (and redistribute from) the peripheral compartments
* Plasma concentration will depend on:
	* Rate of drug delivery
	* Rate of drug distribution and redistribution
	* Rate of drug elimination

**Effect-Site:**  
<object data="resources\3compartment+effect.svg" type="image/svg+xml"></object>

* Drug distributes to the effect site from the central compartment
* Effect site has no volume, but does have rate constants
* t<sub>1/2</sub>ke0 is generally drawn with drug being eliminated from the effect site, however in reality this does not occur as drug should only be eliminated from the central compartment

###Pharmacokinetics
[**Zero-order kinetics:**](metabolism.md#kin)  
<object data="resources\zero-order-kinetics.svg" type="image/svg+xml"></object>
* A constant amount of drug is eliminated per unit time
* Half-life is not a constant value  
Half-life progressively shortens, as the time taken to go from 50% to 25% is half the time it took to go from 100% to 50%.

[**First-Order Kinetics:**](metabolism.md#kin)  
<object data="resources\first-order-kinetics.svg" type="image/svg+xml"></object>
* A constant proportion of drug is eliminated per unit time
* Half-life is a constant value

	
[**Biexponential elimination:**](pharmacokinetic_modelling#bi)
<object data="resources\biexponent.svg" type="image/svg+xml"></object>
* Note that concentration has been log-transformed
* This describes the elimination of drug from a two compartment model




###Pharmacodynamics
**Isobologram:**
<object data="resources\isobologram.svg" type="image/svg+xml"></object>
* Plots a line of equal clinical effect between two drug concentrations

<object data="resources\plasma-site-targeting.svg" type="image/svg+xml"></object>

<object data="resources\effect-site-targeting.svg" type="image/svg+xml"></object>





##Statistics
<object data="resources\normaldist.svg" type="image/svg+xml"></object>


<object data="resources\boxplot.svg" type="image/svg+xml"></object>

<object data="resources\forest.svg" type="image/svg+xml"></object>



##Respiratory
###Oxygen
<object data="resources\o2cascade.svg" type="image/svg+xml"></object>

<object data="resources\oxyhb-curve.svg" type="image/svg+xml"></object>

<object data="resources\oxy-hb-curve-shifts.svg" type="image/svg+xml"></object>

<object data="resources\Oxyhb-curve-double-bohr.svg" type="image/svg+xml"></object>

<object data="resources\PaO2-vs-MV.svg" type="image/svg+xml"></object>

<object data="resources\isoshunt.svg" type="image/svg+xml"></object>


###Carbon Dioxide

<object data="resources\co2-dissociation-curve.svg" type="image/svg+xml"></object>

<object data="resources\fev1-and-fvc.svg" type="image/svg+xml"></object>

<object data="resources\paco2-vs-MV.svg" type="image/svg+xml"></object>

<object data="resources\VA-vs-paco2.svg" type="image/svg+xml"></object>



###Anatomical and Physiological Interactions
<object data="resources\closing-capacity-vs-age.svg" type="image/svg+xml"></object>

<object data="resources\diffusion-vs-perfusion-limitation.svg" type="image/svg+xml"></object>

<object data="resources\regional-ventilation-and-perfusion.svg" type="image/svg+xml"></object>

<object data="resources\airway-gen-vs-resistance.svg" type="image/svg+xml"></object>

<object data="resources\lungvol-vs-airway-resistance.svg" type="image/svg+xml"></object>

<object data="resources\pap-vs-pvr.svg" type="image/svg+xml"></object>

<object data="resources\lung-pressure-volume.svg" type="image/svg+xml"></object>

<object data="resources\workofbreathing.svg" type="image/svg+xml"></object>

<object data="resources\workofbreathing-obstructive.svg" type="image/svg+xml"></object>

<object data="resources\First-Breath.svg" type="image/svg+xml"></object>



###Anaesthetic Agents


<object data="resources\fa-fao.svg" type="image/svg+xml"></object>

<object data="resources\fa-fi.svg" type="image/svg+xml"></object>

##Cardiovascular

<object data="resources\LV-cbf.svg" type="image/svg+xml"></object>

<object data="resources\RV-cbf.svg" type="image/svg+xml"></object>

<object data="resources\baroreceptors.svg" type="image/svg+xml"></object>

<object data="resources\cardiac-function.svg" type="image/svg+xml"></object>

<object data="resources\Wiggers.svg" type="image/svg+xml"></object>

<object data="resources\starling-curve.svg" type="image/svg+xml"></object>

<object data="resources\starling-curve-failing.svg" type="image/svg+xml"></object>


###Action Potentials
<object data="resources\pacemaker-currents.svg" type="image/svg+xml"></object>

<object data="resources\pacemaker-phases.svg" type="image/svg+xml"></object>

<object data="resources\pacemaker-shifts.svg" type="image/svg+xml"></object>


<object data="resources\ventricular-ap.svg" type="image/svg+xml"></object>

<object data="resources\ventricular-ap-hyperk.svg" type="image/svg+xml"></object>

###Antiarrhythmics
<object data="resources\ventricular-ap-Ia.svg" type="image/svg+xml"></object>

<object data="resources\ventricular-ap-Ib.svg" type="image/svg+xml"></object>

<object data="resources\ventricular-ap-Ic.svg" type="image/svg+xml"></object>

<object data="resources\pacemaker-betablock.svg" type="image/svg+xml"></object>

<object data="resources\ventricular-ap-III.svg" type="image/svg+xml"></object>

<object data="resources\pacemaker-cablock.svg" type="image/svg+xml"></object>

##CNS
<object data="resources\monroe-kellie.svg" type="image/svg+xml"></object>

<object data="resources\CPP-vs-CBF.svg" type="image/svg+xml"></object>

<object data="resources\PaCO2-vsCBF.svg" type="image/svg+xml"></object>

<object data="resources\PaO2-vs-CBF.svg" type="image/svg+xml"></object>

<object data="resources\temp-vs-CBF.svg" type="image/svg+xml"></object>



##Renal & Acid-Base
<object data="resources\pkas-acids.svg" type="image/svg+xml"></object>

<object data="resources\renal-autoregulation.svg" type="image/svg+xml"></object>

<object data="resources\gfr-vs-creatinine.svg" type="image/svg+xml"></object>

<object data="resources\glucoseflux.svg" type="image/svg+xml"></object>




##Haematology
<object data="resources\Coagulation_full.svg" type="image/svg+xml"></object>


##Other
<object data="resources\heat-loss.svg" type="image/svg+xml"></object>

<object data="resources\pgsynth.svg" type="image/svg+xml"></object>



##Equipment & Measurement
<object data="resources\einthovens.svg" type="image/svg+xml"></object>

<object data="resources\damping.svg" type="image/svg+xml"></object>

<object data="resources\damping2.svg" type="image/svg+xml"></object>

<object data="resources\wheatstone.svg" type="image/svg+xml"></object>


###Gas Analysis
<object data="resources\clark-electrode.svg" type="image/svg+xml"></object>

<object data="resources\ph-electrode.svg" type="image/svg+xml"></object>

<object data="resources\severinghaus.svg" type="image/svg+xml"></object>



###Capnography
<object data="resources\capno-normal.svg" type="image/svg+xml"></object>

<object data="resources\capno-obstruction.svg" type="image/svg+xml"></object>

<object data="resources\capno-rebreathing.svg" type="image/svg+xml"></object>

<object data="resources\capno-hyperventilation.svg" type="image/svg+xml"></object>


##Structure-Activity Relationships
###Sympathomimetics
<object data="resources\phenylethylamine.svg" type="image/svg+xml"></object>

<object data="resources\dopamine bare.svg" type="image/svg+xml"></object>

<object data="resources\dopamine.svg" type="image/svg+xml"></object>

<object data="resources\noradrenaline bare.svg" type="image/svg+xml"></object>

<object data="resources\noradrenaline.svg" type="image/svg+xml"></object>

<object data="resources\adrenaline bare.svg" type="image/svg+xml"></object>

<object data="resources\adrenaline.svg" type="image/svg+xml"></object>


<object data="resources\metaraminol bare.svg" type="image/svg+xml"></object>

<object data="resources\metaraminol.svg" type="image/svg+xml"></object>

<object data="resources\ephedrine bare.svg" type="image/svg+xml"></object>

<object data="resources\ephedrine.svg" type="image/svg+xml"></object>

<object data="resources\phenylephrine bare.svg" type="image/svg+xml"></object>

<object data="resources\phenylephrine.svg" type="image/svg+xml"></object>

###Anaesthetic Agents
<object data="resources\desflurane.svg" type="image/svg+xml"></object>

<object data="resources\sevoflurane 2.svg" type="image/svg+xml"></object>

<object data="resources\isoflurane 1.svg" type="image/svg+xml"></object>

<object data="resources\enflurane.svg" type="image/svg+xml"></object>

<object data="resources\Propofol.svg" type="image/svg+xml"></object>

---